Skip to main content

Rydym wedi cadw rhai ffeiliau o'r enw cwcis ar eich dyfais. Y cwcis hyn yw:

  • Hanfodol ar gyfer y safle i weithio
  • Helpu i wella ein gwefan drwy gasglu ac adrodd gwybodaeth am sut rydych chi'n ei defnyddio

Hoffem hefyd arbed rhai cwcis i helpu i deilwra cyfathrebu.

BETA
Rydych yn edrych ar fersiwn wedi'i ddiweddaru o'r gwasanaeth hwn - bydd eich adborth yn ein helpu i'w wella.

UK5

Inherited Cancer Genetic Testing

  • Cyhoeddwyd gyntaf: 16 Medi 2025
  • Wedi'i addasu ddiwethaf: 16 Medi 2025
  • Cofnodi Diddordeb

     

  • Efallai na fydd y ffeil hon yn gwbl hygyrch.

  •  

Cynnwys

Crynodeb

OCID:
ocds-h6vhtk-059b82
Cyhoeddwyd gan:
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
ID Awudurdod:
AA0221
Dyddiad cyhoeddi:
16 Medi 2025
Dyddiad Cau:
-
Math o hysbysiad:
UK5
Mae ganddo ddogfennau:
Nac Ydi
Wedi SPD:
Nac Ydi
Mae ganddo gynllun lleihau carbon:
AMH

Crynodeb

This notice is to inform the public of a direct award for the provision of inherited cancer genetic testing services. The service is essential for the timely and accurate diagnosis of hereditary cancer syndromes, supporting clinical decision-making and patient care across NHS Wales. The contract has been awarded to a specialist provider with proven expertise and capability in delivering high-quality genetic testing aligned with national genomic standards. The award ensures continuity of service, compliance with clinical governance, and supports the strategic objectives of Genomics Partnership Wales.

Testun llawn y rhybydd

Cwmpas

Cyfeirnod caffael

CAV-DCO (25-26) 85

Disgrifiad caffael

This notice is to inform the public of a direct award for the provision of inherited cancer genetic testing services. The service is essential for the timely and accurate diagnosis of hereditary cancer syndromes, supporting clinical decision-making and patient care across NHS Wales. The contract has been awarded to a specialist provider with proven expertise and capability in delivering high-quality genetic testing aligned with national genomic standards. The award ensures continuity of service, compliance with clinical governance, and supports the strategic objectives of Genomics Partnership Wales.

Awdurdod contractio

Cardiff and Vale University Health Board

Cofrestr adnabod:

  • GB-PPON

Cyfeiriad 1: Woodland House, Maes-Y-Coed Road

Tref/Dinas: Cardiff

Côd post: CF14 4HH

Gwlad: United Kingdom

Gwefan: http://nwssp.nhs.wales/ourservices/procurement-services/

Rhif y Sefydliad Caffael Cyhoeddus: PPPR-7969-BTJG

Enw cyswllt: nicola

Ebost: nicola.williams33@wales.nhs.uk

Math o sefydliad: Awdurdod cyhoeddus - llywodraeth is-ganolog

Rheoliadau datganoledig sy'n berthnasol: Cymru

Cyflenwr

Informed Genetics

Cofrestr adnabod:

  • GB-PPON

Cyfeiriad 1: Unit 5, quinton business park, 11 Ridgeway,

Tref/Dinas: Birmingham

Côd post: B32 1AF

Gwlad: United Kingdom

Rhif y Sefydliad Caffael Cyhoeddus: PZXY-1897-VDDJ

Ebost: Izzie.Coakley@nonacus.com

Math:

  • Mawr

Gweithdrefn

Math o weithdrefn

Direct award

Disgrifiad o sut mae'r cyfiawnhad hwn yn berthnasol

The decision to proceed with a direct award to the current supplier is based on the supplier’s proven track record of delivering consistent, high-quality service and their deep understanding of our operational requirements. Maintaining continuity with the existing supplier ensures minimal disruption, preserves established workflows, and avoids the additional costs and risks associated with transitioning to a new provider. Furthermore, the supplier has demonstrated a strong commitment to partnership and continuous improvement, aligning well with our strategic objectives.

Cyfiawnhad dyfarniad uniongyrchol

Rhesymau technegol cyflenwyr sengl

Telerau a risgiau contract

Disgrifiad o risgiau i berfformiad contract

Changing suppliers at this stage presents several risks to contract performance, including potential service disruption, loss of operational continuity, and increased costs associated with onboarding a new provider. The current supplier has established familiarity with Cardiff and Vale university Health Board systems and processes, and replacing them could lead to delays, reduced efficiency, and quality issues during the transition period. Maintaining the existing relationship helps mitigate these risks and ensures consistent delivery aligned with organisational expectations.

Lotiau

Wedi'i rannu'n 1 lot

Rhif lot: 1 Statws: Cyflawn

Cytundeb

Inherited Cancer Genetics

ID: 1

Statws: Arfaeth

Lotiau cysylltiedig

1

Dyddiad y caiff y contract ei lofnodi (amcangyfrif)

06 Hydref 2025, 23:59yh

Gwerth

450000.00 GBP Heb gynnwys TAW

540000.00 GBP Gan gynnwys TAW

Prif gategori

Gwasanaethau

Dosbarthiadau CPV

  • 85148000 - Gwasanaethau dadansoddi meddygol

Rhanbarthau cyflawni

  • UKL22 - Cardiff and Vale of Glamorgan

A yw cyfanswm y gwerth uwchlaw'r trothwy?

Uwchben y trothwy

Dyddiadau contract (amcangyfrif)

01 Ionawr 2026, 00:00yb to 31 Rhagfyr 2026, 23:59yh

Cyflenwyr

  • GB-PPON-PZXY-1897-VDDJ

Codio

Categorïau nwyddau

ID Teitl Prif gategori
85148000 Gwasanaethau dadansoddi meddygol Gwasanaethau iechyd amrywiol

Lleoliadau Dosbarthu

ID Disgrifiad
1022 Caerdydd a Bro Morgannwg

Ynglŷn â'r prynwr

Prif gyswllt:
n/a
Cyswllt gweinyddol:
n/a
Cyswllt technegol:
n/a
Cyswllt arall:
n/a

Gwybodaeth bellach

Dyddiad Manylion

0800 222 9004

Mae'r llinellau ar agor rhwng 8:30am a 5pm o ddydd Llun i ddydd Gwener.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.